RNAI-MEDIATED SILENCING OF MATRIX METALLOPROTEINASE 1 IN EPIDERMAL KERATINOCYTES INFLUENCES THE BIOLOGICAL EFFECTS OF INTERLEUKIN 17A

Matrix metalloproteinases (MMPs) are important for the pathogenesis of psoriasis and other autoimmune disorders. In the extracellular matrix, accumulation of proinflammatory cytokines, such as interleukin 17A (IL-17A), leads to induction of several MMPs, including MMP1. MMPs change the composition and other properties of the extracellular matrix. These changes facilitate tissue remodeling and promote the development of psoriatic plaques. The aim of this study was to explore how MMP1 silencing might influence the biological effects of IL-17A on migration and proliferation of human epidermal keratinocytes and the expression of genes involved in their division and differentiation. The experiments were performed with MMP1-deficient and control epidermal keratinocytes, HaCaT-MMP1 and HaCaT-KTR, respectively. Cell proliferation and migration were assessed by comparative analysis of the growth curves and scratch assay, respectively. To quantify cell migration, representative areas of cell cultures were photographed at the indicated time points and compared to each other. Changes in gene expression were analyzed by real-time PCR. The obtained results demonstrated that MMP1 silencing in the cells treated with IL-17A resulted in downregulation of MMP9 and -12, FOSL1, CCNA2, IVL, KRT14 and -17 as well as upregulation of MMP2, CCND1 and LOR. Moreover, MMP1 silencing led to a decrease in cell proliferation and an impairment of cell migration. Thus, MMP1-deficiency in epidermal keratinocytes can be beneficial for psoriasis patients that experience an accumulation of IL-17 in lesional skin. Knocking MMP1 down could influence migration and proliferation of epidermal keratinocytes in vivo, as well as help to control the expression of MMP1, -2, -9 и -12, CCNA2, CCND1, KRT14 and -17 that are crucial for the pathogenesis of psoriasis

Protein interference for regulation of gene expression in plants

Transcription factors (TFs) play a central role in the gene regulation associated with a plant's development and its response to the environmental factors. The work of TFs is well regulated at each stage of their activities. TFs usually consist of three protein domains required for DNA binding, dimerization, and transcriptional regulation. Alternative splicing (AS) produces multiple proteins with varying composition of domains. Recent studies have shown that AS of some TF genes form small proteins (small interfering peptide/small interfering protein, siPEP/siPRoT), which lack one or more domains and negatively regulate target TFs by the mechanism of protein interference (peptide interference/protein interference, PEPi/PROTi). The presence of an alternative form for the transcription factor CCA1 of Arabidopsis thaliana, has been shown to be involved in the regulation of the response to cold stress. For the PtFLC protein, one of the isoforms was found, which is formed as a result of alternative splicing and acts as a negative repressor, binding to the full-length TF PtFLC and therefore regulating the development of the Poncirus trifoliata. For A. thaliana, a FLM gene was found forming the FLM-б isoform, which acts as a dominant negative regulator and stimulates the development of the flower formation process due to the formation of a heterodimer with SVP TF. Small interfering peptides and proteins can actively participate in the regulation of gene expression, for example, in situations of stress or at different stages of plant development. Moreover, small interfering peptides and proteins can be used as a tool for fundamental research on the function of genes as well as for applied research for permanent or temporary knockout of genes. In this review, we have demonstrated recent studies related to siPEP/siPROT and their involvement in the response to various stresses, as well as possible ways to obtain small proteins

Possible Impurities in Radiopharmaceuticals and Corresponding Test Methods

The main quality attributes of radiopharmaceuticals that ensure their effectiveness and safety and are unique to their specifications are activity, radionuclide identity, radionuclide purity, and radiochemical purity. The aim of this study was to analyse the possibility of formation and methods for determination of various impurities in radiopharmaceuticals based on radionuclides of several groups: technetium-99m and rhenium-188; iodine and fluorine-18 isotopes; and gallium-68 and some other metallic radionuclides used in theranostic schemes combining radionuclide diagnostics and radionuclide therapy. The article analyses the sources for the formation of radionuclide, radiochemical, and chemical impurities; the influence of these impurities on visualisation quality and dosimetric characteristics of radiopharmaceuticals; various approaches to the methods of impurity detection and quantification; compendial requirements to the quality of radiopharmaceuticals; and research results reported in publications. The article demonstrates the need for the development and certification of Russian reference standards for testing quality attributes of radiopharmaceuticals as part of harmonisation of the State Pharmacopoeia of the Russian Federation with the Pharmacopoeia of the Eurasian Economic Union and the European Pharmacopoeia

Spatial and Wavenumber Resolution of Doppler Reflectometry

Doppler reflectometry spatial and wavenumber resolution is analyzed within the framework of the linear Born approximation in slab plasma model. Explicit expression for its signal backscattering spectrum is obtained in terms of wavenumber and frequency spectra of turbulence which is assumed to be radially statistically inhomogeneous. Scattering efficiency for both back and forward scattering (in radial direction) is introduced and shown to be inverse proportional to the square of radial wavenumber of the probing wave at the fluctuation location thus making the spatial resolution of diagnostics sensitive to density profile. It is shown that in case of forward scattering additional localization can be provided by the antenna diagram. It is demonstrated that in case of backscattering the spatial resolution can be better if the turbulence spectrum at high radial wavenumbers is suppressed. The improvement of Doppler reflectometry data localization by probing beam focusing onto the cut-off is proposed and described. The possibility of Doppler reflectometry data interpretation based on the obtained expressions is shown.Comment: http://stacks.iop.org/0741-3335/46/114

Присутствие возможных примесей в радиофармацевтических лекарственных препаратах и методы их определения

The main quality attributes of radiopharmaceuticals that ensure their effectiveness and safety and are unique to their specifications are activity, radionuclide identity, radionuclide purity, and radiochemical purity. The aim of this study was to analyse the possibility of formation and methods for determination of various impurities in radiopharmaceuticals based on radionuclides of several groups: technetium-99m and rhenium-188; iodine and fluorine-18 isotopes; and gallium-68 and some other metallic radionuclides used in theranostic schemes combining radionuclide diagnostics and radionuclide therapy. The article analyses the sources for the formation of radionuclide, radiochemical, and chemical impurities; the influence of these impurities on visualisation quality and dosimetric characteristics of radiopharmaceuticals; various approaches to the methods of impurity detection and quantification; compendial requirements to the quality of radiopharmaceuticals; and research results reported in publications. The article demonstrates the need for the development and certification of Russian reference standards for testing quality attributes of radiopharmaceuticals as part of harmonisation of the State Pharmacopoeia of the Russian Federation with the Pharmacopoeia of the Eurasian Economic Union and the European Pharmacopoeia.Основными показателями качества любого радиофармацевтического лекарственного препарата, которые обеспечивают его эффективность и безопасность, и при этом отсутствуют в спецификациях других лекарственных средств, являются подлинность по радионуклиду, активность, радионуклидная чистота и радиохимическая чистота. Цель работы – анализ возможности образования различных видов примесей в радиофармацевтических лекарственных препаратах и методов определения этих примесей. Рассмотрены препараты на основе радионуклидов различных групп: технеция-99м и рения-188; изотопов йода и фтора-18; галлия-68 и некоторых других радионуклидов-металлов, применяемых в тераностических схемах «радионуклидная диагностика/радионуклидная терапия». Проанализированы источники образования радионуклидных, радиохимических и химических примесей, их влияние на качество визуализации и дозиметрические характеристики радиофармпрепаратов, различные подходы к методам обнаружения и количественного определения примесей,  фармакопейные требования к качеству радиофармпрепаратов и результаты исследований, опубликованные в научной литературе. Показана необходимость разработки и аттестации отечественных стандартных образцов для определения показателей качества радиофармацевтических лекарственных препаратов в рамках гармонизации отечественной фармакопеи с Фармакопеей Евразийского экономического союза и Европейской фармакопеей